Bolte Axel
Chief Executive Officer at Inozyme Pharma, Inc.; Director at IVERIC bio, Inc.
- Sold, on record
- $29k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jun 24, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Inozyme Pharma, Inc.Chief Executive Officer
- IVERIC bio, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Inozyme Pharma, Inc.66,788 shares
- IVERIC bio, Inc.6,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale IVERIC bio, Inc.UnusualDec 30, 2016 2016
Sold 6,000 shares at $4.83 ($29k)
Bolte Axel, Director
Sold 100% of holdings ($29k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Inozyme Pharma, Inc.UnusualJun 24, 2021 +1637 days
Sold 66,788 shares
Bolte Axel, Chief Executive Officer
Sold 25.9% of holdings190,825 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2021 | Jun 25, 2021 | Inozyme Pharma, Inc. | Chief Executive Officer | Form 4 sale | 66,788 | 25.9% | Unusual | SEC | |
| Dec 30, 2016 | Jan 23, 2017 | IVERIC bio, Inc. | Director | Form 4 sale | 6,000 | $29k | 100.0% | Unusual | SEC |